These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14264432)

  • 1. SERUM INSULIN-LIKE ACTIVITY AFTER TOLBUTAMIDE DURING PREGNANCY AND EARLY PUERPERIUM.
    LEAKE NH; BURT RL
    Obstet Gynecol; 1965 Feb; 25():245-8. PubMed ID: 14264432
    [No Abstract]   [Full Text] [Related]  

  • 2. DIABETOGENIC FACTORS ASSOCIATED WITH PREGNANCY.
    KALKHOFF R; SCHALCH DS; WALKER JL; BECK P; KIPNIS DM; DAUGHADAY WH
    Trans Assoc Am Physicians; 1964; 77():270-80. PubMed ID: 14275427
    [No Abstract]   [Full Text] [Related]  

  • 3. [The tolbutamide effect in normal pregnancy].
    Herre HD; Falkenthal S; Lenz P
    Z Geburtshilfe Gynakol; 1968; 169(3):310-20. PubMed ID: 5710359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intravenous tolbutamide loading, serum insulin activity (ILA) and tolbutamide stimulated insulin reserve in patients with acne vulgaris].
    Denk R; Knick B; Linde K
    Z Haut Geschlechtskr; 1966 Dec; 41(11):429-34. PubMed ID: 4226565
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental hyperglycemia during pregnancy and the puerperium in suspect prediabetic patients with observations on serum insulin.
    Burt RL; Leake NH; Rhyne AL
    Obstet Gynecol; 1972 Mar; 39(3):446-52. PubMed ID: 5019320
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of the tolbutamide test in the puerperium].
    Allner R; Awini A; Göltner E
    Med Welt; 1974 Nov; 25(44):1800-2. PubMed ID: 4431319
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.
    Boden G; Soeldner JS; Gleason RE; Marble A
    J Clin Invest; 1968 Apr; 47(4):729-39. PubMed ID: 5641614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tolbutamide on lipolytic processes in blood and fat tissue of rats maintained in normothermic and hypothermic conditions].
    Koźlik J; Paluszak J; Bryl A; Witmanowski H; Grzymisławski M; Torlińska T
    Endokrynol Pol; 1991; 42(4):519-28. PubMed ID: 1364502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 10. HYPERLIPEMIA AND KETOSIS IN THE PREGNANT RAT.
    SCOW RO; CHERNICK SS; BRINLEY MS
    Am J Physiol; 1964 Apr; 206():796-804. PubMed ID: 14166175
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous administration of insulin and tolbutamide. A mathematical simulation on the different glycolytic activity in the organism (author's transl)].
    Geiseler D; Schmüling R
    Arzneimittelforschung; 1979; 29(5):823-7. PubMed ID: 582980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
    Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H
    Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variations of insulinemia and glycemia compared in the course of an intravenous tolbutamide test in 29 persons].
    Vague J; Depieds R; Codaccioni JL; Vague P; Boeuf G
    Bull Mem Soc Med Hop Paris; 1965 Oct; 116(13):Suppl:1367-81. PubMed ID: 5859607
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolbutamide-induced insulin release in pregnant diabetics.
    Notelovitz M; James S
    Horm Metab Res; 1977 May; 9(3):167-72. PubMed ID: 885466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THE TOLBUTAMIDE TEST IN PATIENTS HAVING UNDERGONE GASTRIC RESECTION].
    ROSS G
    Dtsch Med J; 1964 Nov; 15():726-30. PubMed ID: 14324902
    [No Abstract]   [Full Text] [Related]  

  • 16. [SIGNIFICANCE OF THE TOLBUTAMIDE INTRAVENOUS TEST (RASTINON TEST) IN THE DIAGNOSIS OF PREDIABETES].
    YAMADA K; SHIBATA M; ITO K; SAKAMOTO N; KOIDE T; AOYAMA K; KATSUMATA K; NIKKI A; TSUCHIDA I; NONOGAKI N; HISANO T
    Sogo Rinsho; 1964 Apr; 13():710-8. PubMed ID: 14142734
    [No Abstract]   [Full Text] [Related]  

  • 17. [DIAGNOSTIC VALUE OF INTRAVENOUS INJECTIONS OF TOLBUTAMIDE IN DIABETES MELLITUS].
    ONO T; MURATA T; HOSOSERI A; KUDO K
    Chiryo; 1963 Oct; 45():1835-42. PubMed ID: 14094257
    [No Abstract]   [Full Text] [Related]  

  • 18. MEASUREMENT OF GLUCOSE DISPOSAL RATES IN NORMAL AND DIABETIC HUMAN SUBJECTS AFTER REPEATED INTRAVENOUS INJECTIONS OF GLUCOSE.
    STREETEN DH; GERSTEIN MM; WOOLFOLK D; DOISY RJ
    J Clin Endocrinol Metab; 1964 Aug; 24():761-74. PubMed ID: 14202755
    [No Abstract]   [Full Text] [Related]  

  • 19. [ACTIVITY OF BETA-GLUCURONIDASE OF THE BLOOD SERUM IN MENSTRUATING, PREGNANT AND PUERPERAL WOMEN].
    OZIEBLO L; PASZKO Z
    Ginekol Pol; 1964; 35():361-5. PubMed ID: 14256125
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of tolbutamide and butylbiguanide on the blood sugar level and level of immunoreductive serum insulin after a glucose infusion in healthy subjects (author's transl)].
    Brodan V; Slabochová Z; Brodanová M; Kuhn E
    Cesk Gastroenterol Vyz; 1975 Mar; 29(2):89-93. PubMed ID: 1131869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.